10.1016/j.ijbiomac.2023.125814 86 FrangiehJ.SalmaY.HaddadK.MatteiC.LegrosC.FajlounZ.et al (2019)
Huberman launched the Huberman Lab podcast
Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autnoma de Mxico, Colonia Chamilpa, 62210, Cuernavaca, Morelos, Mxico
there are several FDA-approved ones Growth hormone itself is a peptide hormone, not a steroid hormone Taking growth hormone or growth hormone-releasing peptides has serious risks: tumor growth and cancer Type 1 diabetics have very high growth hormone but low IGF-1 paradoxically, and they have very high rates of various cancers The benefits (lipolysis, decreased body fat, increased lean mass) can be achieved through other means, and cosmetic benefits (hair, skin, nails) can be achieved using topicals Most people dont actually need growth hormone-releasing peptides BPC 157 is body protective compound 157, identical to gastric protective compound 157 produced in your stomach As you age, you get atrophic gastritis, which is why you have less intrinsic factor and more colitis and diverticulitis BPC 157 increases VEGF (vascular endothelial growth factor), which makes blood vessels grow Avastin is on the WHOs list of essential cancer medications, and its a VEGF inhibitor, so if you have cancer or high cancer risk, avoid BPC 157 since it does the opposite BPC 157 isnt FDA approved, but its basically standard of care now, one of the most commonly used peptides Dont take it 2-3 times a week for six weeks, no matter what
Adaptive planning needs to integrate technical evidence to inform decision making with adaptive processes to pragmatically address and learn from emerging challenges
